BPC-157 vs TB-500: Comparing Two Research Peptides
BPC-157 and TB-500 are two of the most frequently studied compounds in tissue and structural research, and they are often mentioned together. They are, however, quite different molecules with different origins and different mechanisms in the research literature. This article compares them.
This comparison covers documented research characteristics only. It does not describe or endorse any human or veterinary use.
Origins
BPC-157 (CAS 137525-51-0) is a synthetic pentadecapeptide — a 15-amino-acid chain. Its sequence is derived from a portion of a protein found in gastric juice, which is where the name comes from: Body Protection Compound.
TB-500 (CAS 77591-33-4) is a synthetic fragment corresponding to a region of Thymosin Beta-4, a naturally occurring protein present in most cell types. TB-500 is not identical to Thymosin Beta-4 — it is a shorter fragment representing the active region studied in the literature.
Structural difference
The practical distinction is that these are structurally unrelated molecules. BPC-157 is a gastric-derived peptide sequence; TB-500 is a fragment of a cytoskeletal protein. They are grouped together in research discussion because of overlapping areas of study, not because of any structural similarity.
Research focus
BPC-157 appears in research literature primarily in connection with gastrointestinal tissue models and localised soft-tissue studies. A substantial portion of the published work concerns gut-lining research models.
TB-500 research is more commonly associated with actin binding. Thymosin Beta-4 is documented as an actin-sequestering protein, and actin is a fundamental component of the cellular cytoskeleton involved in cell structure and cell migration. Research involving TB-500 frequently examines this cytoskeletal angle.
So while both compounds appear in tissue-repair research contexts, the mechanistic questions researchers ask about them differ: BPC-157 work often centres on localised tissue models, TB-500 work often centres on actin dynamics and cell migration.
Why they are studied together
Because their proposed mechanisms are distinct rather than overlapping, researchers investigating tissue models frequently examine them in combination to observe whether combined activity differs from either compound alone. This is why blends exist — our BPC-157 / TB-500 blend supplies both compounds in a single vial for exactly this kind of comparative work.
Practical differences in handling
Both are supplied lyophilised and reconstituted using the same standard laboratory technique. Both should be stored cold and protected from light, both as powder and once in solution. Neither requires special handling relative to the other.
Which to select for research
That depends entirely on the research question. Work concerning gastrointestinal or localised tissue models more commonly references BPC-157. Work concerning actin dynamics or cell migration more commonly references TB-500. Comparative or combination studies use both.
Verification
Both compounds in our catalogue are independently analysed by third-party laboratory using HPLC-MS, with batch-specific Certificates of Analysis published on our Lab Results page. You can review the exact paperwork for the batch you receive, including the chromatogram.
Research use only. All compounds referenced are intended strictly for laboratory and analytical research. They are not medicines, supplements or therapeutic goods, and are not for human or veterinary consumption.